MISO Chip
misochip.com
Actively hiring
Oncology Therapeutics
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Frontrow
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2019
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Frontrow Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. It preserves…
LynxBio is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated…
Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
What if we made as many cancer drugs next year as we have in the last decade?
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict…
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.